Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1964 2
1973 1
1974 2
1975 3
1976 10
1977 6
1978 4
1979 3
1980 12
1981 6
1982 9
1983 7
1984 11
1985 13
1986 16
1987 17
1988 14
1989 17
1990 25
1991 26
1992 34
1993 42
1994 42
1995 43
1996 52
1997 60
1998 56
1999 81
2000 78
2001 66
2002 77
2003 88
2004 90
2005 102
2006 106
2007 152
2008 125
2009 140
2010 170
2011 152
2012 202
2013 237
2014 261
2015 251
2016 219
2017 237
2018 286
2019 264
2020 286
2021 265
2022 226
2023 253
2024 80

Text availability

Article attribute

Article type

Publication date

Search Results

4,369 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Resectable Digestive System Carcinoma"
Page 1
Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study.
Pu N, Wu W, Liu S, Xie Y, Yin H, Chen Q, He T, Xu Z, Wang W, Yu J, Liu L, Lou W. Pu N, et al. Int J Surg. 2023 Oct 1;109(10):3137-3146. doi: 10.1097/JS9.0000000000000589. Int J Surg. 2023. PMID: 37418574 Free PMC article.
The objective of this study is to further assess the clinical benefit and impact of systemic AC in patients with resected PDAC after NAC. METHODS: Data on PDAC patients with or without AC following systemic NAC and surgical resection were retrospectively retrieved f …
The objective of this study is to further assess the clinical benefit and impact of systemic AC in patients with resected PDAC after …
Pathology of combined hepatocellular-cholangiocarcinoma.
Yeh MM. Yeh MM. J Gastroenterol Hepatol. 2010 Sep;25(9):1485-92. doi: 10.1111/j.1440-1746.2010.06430.x. J Gastroenterol Hepatol. 2010. PMID: 20796144 Review.
It has gained increasing recognition recently, which in part may be due to more extensive sampling of the explants and surgical resection specimens, the diagnostic challenges encountered in the clinical practice, and the yet to be determined clinical outcome, but partly ma …
It has gained increasing recognition recently, which in part may be due to more extensive sampling of the explants and surgical resection …
Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
Scott A, Wong P, Melstrom LG. Scott A, et al. Surgery. 2023 Jul;174(1):113-115. doi: 10.1016/j.surg.2023.01.019. Epub 2023 Mar 9. Surgery. 2023. PMID: 36906437 Review.
Intrahepatic cholangiocarcinoma is an aggressive tumor that commonly presents at an advanced stage requiring multimodal treatment. Surgical resection remains the only curative option; however, only 20% to 30% of patients present with resectable disease as these tumo …
Intrahepatic cholangiocarcinoma is an aggressive tumor that commonly presents at an advanced stage requiring multimodal treatment. Surgical …
Operative management of cholangiocarcinoma.
Lee SY, Cherqui D. Lee SY, et al. Semin Liver Dis. 2013 Aug;33(3):248-61. doi: 10.1055/s-0033-1351784. Epub 2013 Aug 13. Semin Liver Dis. 2013. PMID: 23943105 Review.
It is the second most-common primary liver cancer after hepatocellular carcinoma. Recent epidemiologic studies have shown that the overall incidence and mortality rates of CCAs are increasing. ...Evaluation should be focused on the assessment of tumor resectability, …
It is the second most-common primary liver cancer after hepatocellular carcinoma. Recent epidemiologic studies have shown that the ov …
Diagnosis and management of gastric dysplasia.
Sung JK. Sung JK. Korean J Intern Med. 2016 Mar;31(2):201-9. doi: 10.3904/kjim.2016.021. Epub 2016 Feb 26. Korean J Intern Med. 2016. PMID: 26932397 Free PMC article. Review.
Much evidence suggests that patients with high-grade dysplasia are at high risk of progression to carcinoma or synchronous carcinoma. Therefore, endoscopic resection is required. ...Helicobacter pylori eradication in patients with dysplasia after endoscopic …
Much evidence suggests that patients with high-grade dysplasia are at high risk of progression to carcinoma or synchronous carcino …
Clinical and Histological Basis of Adenosquamous Carcinoma of the Pancreas: A 30-year Experience.
Moslim MA, Lefton MD, Ross EA, Mackrides N, Reddy SS. Moslim MA, et al. J Surg Res. 2021 Mar;259:350-356. doi: 10.1016/j.jss.2020.09.024. Epub 2020 Nov 13. J Surg Res. 2021. PMID: 33190924 Free PMC article. Review.
BACKGROUND: Adenosquamous carcinoma (ASC) of the pancreas is a rare form of malignancy with a poor prognosis. ...The tumor was in the head of the pancreas in 65% of cases. Six cases (26%) had resectable disease, three (13%) were borderline resectable, and eig …
BACKGROUND: Adenosquamous carcinoma (ASC) of the pancreas is a rare form of malignancy with a poor prognosis. ...The tumor was in the …
Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal adenocarcinoma.
Chen H, Xu Z, Shen Z, Weng Y, Wang W, Ying X, Wang X, Deng X, Shen B. Chen H, et al. Eur J Surg Oncol. 2022 May;48(5):1062-1067. doi: 10.1016/j.ejso.2021.11.135. Epub 2021 Dec 2. Eur J Surg Oncol. 2022. PMID: 34887166
BACKGROUND: Surgical resection is recommended for patients with resectable acinar cell carcinoma (ACC). ...After the 1:3 PSM, ACC remained to be a better histological type for OS (p = 0.024), but had comparable RFS with PDAC (p = 0.164). CONCLUSION: Patients …
BACKGROUND: Surgical resection is recommended for patients with resectable acinar cell carcinoma (ACC). ...After the 1: …
Using immunovascular characteristics to predict very early recurrence and prognosis of resectable intrahepatic cholangiocarcinoma.
Xu Y, Li Z, Zhou Y, Yang Y, Ouyang J, Li L, Huang Z, Ye F, Ying J, Zhao H, Zhou J, Zhao X. Xu Y, et al. BMC Cancer. 2023 Oct 19;23(1):1009. doi: 10.1186/s12885-023-11476-z. BMC Cancer. 2023. PMID: 37858111 Free PMC article.
OBJECTIVE: To predict the very early recurrence (VER) of patients with intrahepatic cholangiocarcinoma (ICC) based on TLSs and MVI status, and further perform prognosis stratifications. ...CONCLUSION: Intra-tumoral TLSs and MVI status are independent predictive fact …
OBJECTIVE: To predict the very early recurrence (VER) of patients with intrahepatic cholangiocarcinoma (ICC) based on TLSs and MVI st …
Three-dimensional visualization and evaluation of hilar cholangiocarcinoma resectability and proposal of a new classification.
Zhang JZ, Yang CX, Gao S, Bu JF, Li QQ, Wang HL, Yang KN, Tong SS, Qian LJ, Zhang J, Hua R, Sun YW, Yan JY, Chen W. Zhang JZ, et al. World J Surg Oncol. 2023 Aug 5;21(1):239. doi: 10.1186/s12957-023-03126-2. World J Surg Oncol. 2023. PMID: 37542314 Free PMC article.
Logistic analysis was performed to identify independent risk factors of R0 resection. A new comprehensive 3DVE classification of hCCA based on factors influencing resectability was proposed to investigate its role in predicting R0 resection and prognos …
Logistic analysis was performed to identify independent risk factors of R0 resection. A new comprehensive 3DVE classification of hCCA …
Intraductal papillary neoplasm of the bile duct.
Wan XS, Xu YY, Qian JY, Yang XB, Wang AQ, He L, Zhao HT, Sang XT. Wan XS, et al. World J Gastroenterol. 2013 Dec 14;19(46):8595-604. doi: 10.3748/wjg.v19.i46.8595. World J Gastroenterol. 2013. PMID: 24379576 Free PMC article. Review.
However, pathologic diagnosis by biopsy cannot reflect the actual stage in many cases because different foci may be of different stages and because mixed pathologic findings may exist in the same lesion. Surgical resection is the major treatment. Systematic cholangioscopy …
However, pathologic diagnosis by biopsy cannot reflect the actual stage in many cases because different foci may be of different stages and …
4,369 results